Internal Medicine, Endocrinology, Diabetes, & Metabolism · Sugar Land, TX
NPI
1528194370
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
11555 University Blvd
Sugar Land, TX, 77478
Phone (713) 442-9100
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,425
120 services
Medicare patients, 2024
20
Average age 71
Drug cost, 2024
$2.7M
6,670 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Swarna Kamble was code 36415 (venipuncture blood collection), 26 times for 15 patients. In total Swarna Kamble billed 120 services in 14 codes, and Medicare paid $3,425.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 26 | 15 | $7.60 | $198 |
| 99214 Office E&M - Established | Office | 26 | 17 | $82.75 | $2,152 |
By year: 2022 $3,053 for 42 services; 2023 $3,546 for 105 services; 2024 $3,425 for 120 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 26 | 15 | $7.60 | $198 |
Medicare prescription drug claims, 2024
In 2024, the drug Swarna Kamble prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,004 prescriptions and refills. In total Swarna Kamble wrote 6,670 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,004 | 2,908 | 302 | $3,393 |
| Ozempic Semaglutide | 485 | 653 | 108 | $590K |
| Glipizide Er Glipizide | 429 | 1,218 | 134 | $9,442 |
| Jardiance Empagliflozin | 285 | 541 | 66 | $308K |
| Metformin Hcl Generic | 266 | 740 | 82 | $4,675 |
| Trulicity Dulaglutide | 264 | 364 | 60 | $343K |
| Metformin Hcl Er Metformin Hcl | 253 | 728 | 83 | $5,003 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 223 | 464 | 71 | $108K |
| Novolog Flexpen Insulin Aspart | 198 | 418 | 62 | $43K |
| Mounjaro Tirzepatide | 195 | 197 | 44 | $201K |
| Atorvastatin Calcium Generic | 194 | 578 | 65 | $6,722 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 185 | 364 | 49 | $225K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 176 | 492 | 80 | $18K |
| Rosuvastatin Calcium Generic | 133 | 376 | 45 | $6,175 |
| Synthroid Levothyroxine Sodium | 131 | 332 | 38 | $13K |
Brand drugs: 3,062 claims; generic drugs: 3,278 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Swarna Kamble were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.